Read the Prelim Final Report...One of the few Australian IT success stories and it just keeps getting better.I expect this one to continue its upward trend leading up to the expected announcement at the end of August mentioned in the Report.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%